IL6 and breast carcinoma: Mras, Met, Rantes, IL6, and IL8 are targets of uSTAT3 after stimulation of the cells with IL6 [35], and for breast cancer and head and neck squamous cell carcinoma cyclinB1 and E2f1 were also described as targets of uSTAT3 [38].